Fennec Pharmaceuticals Inc. (FENC)
NASDAQ: FENC · Real-Time Price · USD
4.650
+0.310 (7.14%)
Nov 4, 2024, 4:00 PM EST - Market closed

Fennec Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Net Income
2.74-16.05-23.71-17.35-18.11-12.78
Upgrade
Other Amortization
0.190.290.150.020.40.06
Upgrade
Loss (Gain) From Sale of Investments
0.020.040.180.03-0.1-
Upgrade
Stock-Based Compensation
3.845.354.224.022.883.08
Upgrade
Other Operating Activities
0.8-----
Upgrade
Change in Accounts Receivable
-9.87-7.27-1.55---
Upgrade
Change in Inventory
-0.71-1.58-0.58---
Upgrade
Change in Accounts Payable
1.441.391.61-0.79-0.040.58
Upgrade
Change in Other Net Operating Assets
-1.410.681.61-0.14-0.62-0.01
Upgrade
Operating Cash Flow
23.04-17.14-18.06-14.22-15.6-9.06
Upgrade
Long-Term Debt Issued
-525.175--
Upgrade
Long-Term Debt Repaid
---5-0.01--
Upgrade
Net Debt Issued (Repaid)
5520.174.99--
Upgrade
Issuance of Common Stock
1.941.720.930.0332.43-
Upgrade
Repurchase of Common Stock
-0.14-0.08-0.19---
Upgrade
Other Financing Activities
-1.74--0.18-0.04-0.14-0.07
Upgrade
Financing Cash Flow
5.066.6420.734.9832.29-0.07
Upgrade
Net Cash Flow
28.1-10.512.67-9.2416.69-9.13
Upgrade
Free Cash Flow
23.04-17.14-18.06-14.22-15.6-9.06
Upgrade
Free Cash Flow Margin
47.13%-80.67%-1176.42%--9173.53%-
Upgrade
Free Cash Flow Per Share
0.81-0.65-0.69-0.55-0.66-0.46
Upgrade
Levered Free Cash Flow
-4.87-12.35-9.17-7.73-8.92-4.46
Upgrade
Unlevered Free Cash Flow
-2.53-10.34-8.61-7.66-9.07-4.48
Upgrade
Change in Net Working Capital
10.797.71-1.290.910.76-0.57
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.